As a leading psychiatry practice in Colorado Springs, we see the devastating toll depression takes on individuals and families, especially among low-income communities. Depression—a leading cause of disability worldwide—does not discriminate by socioeconomic status, but its effects are often more acutely by those with limited access to care.
Transcranial Magnetic Stimulation (TMS), a highly effective treatment for depression, is an effective and powerful treatment for patients suffering from depression and treatment-resistant depression. However, Medicaid in Colorado does not yet cover TMS treatment, thus denying many of our most vulnerable residents the benefit of a potentially life-saving option. This must change.
TMS: A Proven Solution for Treatment-Resistant Depression
TMS is an FDA-approved treatment for major depressive disorder (MDD) with substantial research supporting its efficacy. Because TMS addresses depression with a completely different functional mechanism than antidepressants, TMS has proven effective for individuals who have not found relief with antidepressant medications or therapy. TMS also has an advantage over antidepressant medication in that it is generally well-tolerated and does not produce the range of side effects common in those who take antidepressants. Because TMS may be better tolerated, patients are often more likely to continue with treatment and receive the depression relief they need.
The Burden of Depression on Low-Income Communities
Depression is disproportionately prevalent in low-income populations, driven by factors such as chronic stress, financial insecurity, and limited access to healthcare. According to the National Institute of Mental Health (NIMH), individuals living below the poverty line are more than twice as likely to experience depression compared to those with higher incomes. For Medicaid recipients, the challenge is twofold: not only are they more likely to suffer from depression, but they also face significant barriers to accessing effective treatment.
Traditional treatments like antidepressants and talk therapy are not always effective, especially for individuals with severe, treatment-resistant depression. Yet, without Medicaid coverage for TMS, these patients are left with few options. The lack of coverage perpetuates a cycle of suffering, as untreated depression can lead to unemployment, homelessness, and even suicide. Colorado must take a stand to break this cycle by expanding Medicaid to include TMS.
The Case for Medicaid Coverage of TMS
Colorado is one of only a handful of states where Medicaid does not cover TMS. This stands in stark contrast to 16 other states where Medicaid programs have recognized the value of TMS and included it as a covered benefit. States like Arizona, Illinois, and Massachusetts have paved the way, demonstrating that Medicaid coverage for TMS is not only feasible but also impactful in improving mental health outcomes.
Expanding Medicaid coverage for TMS in Colorado would bring numerous benefits:
- Improved Mental Health Outcomes: Providing access to TMS would give Medicaid recipients a powerful tool to combat depression, particularly for those who have exhausted other treatment options. For many patients, TMS is the turning point that allows them to regain control of their lives.
- Cost Savings for the Healthcare System: While TMS may appear costly upfront, it can actually reduce long-term healthcare expenses by decreasing hospitalizations, emergency room visits, and reliance on disability benefits. A study published in the Journal of Clinical Psychiatry found that TMS is cost-effective, particularly for patients with treatment-resistant depression.
- Increased Workforce Participation: Depression is a leading cause of disability, keeping many individuals out of the workforce. By addressing treatment-resistant depression with TMS, more Coloradans could return to work, contributing to the state’s economy and reducing dependence on social services.
Real Stories: The Human Impact of TMS
At Colorado Recovery Solutions we’ve seen the transformative impact of TMS on patients’ lives. Take the example of Sarah (name changed for privacy), a 35-year-old mother of two who had struggled with severe depression for years. Despite trying multiple medications and therapy, her symptoms persisted, leaving her unable to work or care for her children effectively. After completing a course of TMS, Sarah experienced a dramatic improvement. Tasks that seemed impossible before became achievable once again after TMS, enabling Sarah to rebuild her life. She is now employed full-time and actively engaged in her children’s lives. Unfortunately, stories like Sarah’s are far too rare among Medicaid recipients in Colorado, who are unable to access TMS due to lack of coverage.
A Call to Action
The exclusion of TMS from Colorado’s Medicaid program is a glaring inequity that demands immediate attention. Mental health care is not a luxury—it is a necessity. By expanding Medicaid to cover TMS, Colorado can lead the way in addressing treatment-resistant depression and improving mental health outcomes for low-income residents.
We urge policymakers, healthcare advocates, and community leaders to push for this critical change. Colorado’s Medicaid program should reflect the state’s commitment to equity and innovation in healthcare. Expanding coverage for TMS is not just the right thing to do; it is the smart thing to do for the health and well-being of our communities.
Let us not leave our most vulnerable residents behind. It is time to bring TMS within reach for all Coloradans, regardless of income. Together, we can ensure that no one is denied the chance to reclaim their life from the grip of depression.
